Zai Lab Limited
ZLAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.31 | 1.42 | 0.46 | 0.10 |
| FCF Yield | -0.97% | -0.83% | -1.68% | -2.76% |
| EV / EBITDA | -105.57 | -91.74 | -76.29 | -31.40 |
| Quality | ||||
| ROIC | -4.84% | -5.42% | -5.45% | -6.62% |
| Gross Margin | 59.62% | 60.70% | 63.71% | 61.41% |
| Cash Conversion Ratio | 0.89 | 0.76 | 1.27 | 0.68 |
| Growth | ||||
| Revenue 3-Year CAGR | 18.79% | 19.32% | 21.87% | 22.88% |
| Free Cash Flow Growth | -14.42% | 51.84% | 10.82% | -29.66% |
| Safety | ||||
| Net Debt / EBITDA | 16.23 | 15.13 | 12.90 | 3.93 |
| Interest Coverage | -34.87 | -43.50 | -47.44 | -75.10 |
| Efficiency | ||||
| Inventory Turnover | 0.70 | 0.70 | 0.73 | 1.06 |
| Cash Conversion Cycle | 18.88 | -13.78 | -42.25 | -56.72 |